CT-95 in Advanced Cancers Associated With Mesothelin Expression
Public ClinicalTrials.gov record NCT06756035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression
Study identification
- NCT ID
- NCT06756035
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Context Therapeutics Inc.
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
- Cholangiocarcinoma Advanced
- Cholangiocarcinoma Non-resectable
- Colorectal Cancer
- Epithelial Ovarian Cancer
- Lung Adenocarcinoma Metastatic
- Malignant Peritoneal Mesothelioma, Advanced
- Malignant Pleural Mesothelioma, Advanced
- Mesothelin-Expressing Tumors
- Mesothelin-expressing Advanced Cancers
- Mesothelin-positive Advanced Malignant Solid Tumors
- Pancreatic Adenocarcinoma Advanced or Metastatic
Interventions
- CT-95 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2028
- Last update posted
- Jul 30, 2025
2025 – 2028
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Context Investigational Site | Denver | Colorado | 80218 | Recruiting |
| Context Investigational Site | Chicago | Illinois | 60637 | Recruiting |
| Context Investigational Site | Grand Rapids | Michigan | 49546 | Recruiting |
| Context Investigational Site | Hackensack | New Jersey | 07601 | Recruiting |
| Context Investigational Site | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Context Investigational Site | Nashville | Tennessee | 37203 | Recruiting |
| Context Investigational Site | San Antonio | Texas | 78229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06756035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06756035 live on ClinicalTrials.gov.